Lafin, John T.
Murray, Matthew J.
Coleman, Nicholas
Frazier, A. Lindsay
Amatruda, James F
Bagrodia, Aditya http://orcid.org/0000-0002-3358-1193
Funding for this research was provided by:
St. Baldrick's Foundation (358099)
Cancer Prevention and Research Institute of Texas (RP170152)
Rally Foundation
Malignant Germ Cell International Consortium
Dedman Family Foundation
Article History
Accepted: 12 April 2021
First Online: 24 April 2021
Declarations
:
: This work was supported by a St. Baldrick’s Consortium Award under grant 358099 (A.L.F, M.J.M, N.C, and J.F.A.), grant RP170152 from the Cancer Prevention and Research Institute of Texas (A.B. and J.F.A.), A Rally Foundation Award (M.J.M., J.F.A., A.L.F.), the Malignant Germ Cell International Consortium (A.B., M.J.M., A.L.F., J.F.A.), and Dedman Family Scholarship in Clinical Care (A.B).
: John T Lafin, Matthew J Murray, Nicholas Coleman, A. Lindsay Frazier, James F Amatruda, and Aditya Bagrodia have no conflicts of interest that are directly relevant to the content of this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed materially to the creation and editing of this manuscript.
Free to read: This content has been made available to all.